Quanterix to Report Q2 2025 Financial Results on August 7, 2025.

Quanterix will report Q2 2025 financial results on August 7, 2025. The company will host a conference call at 4:30 p.m. E.T. to discuss the results. Quanterix acquired Akoya Biosciences in 2025, adding multiplexed tissue imaging capabilities to its portfolio. The combined company offers an integrated platform for precision medicine from discovery to diagnostics.

Quanterix Corporation (NASDAQ: QTRX), a leading innovator in ultra-sensitive biomarker detection, has scheduled a conference call to discuss its second quarter 2025 financial results. The call is set for Thursday, August 7, 2025, at 4:30 p.m. E.T. [1]

In addition to the financial update, the company will provide insights into its strategic progress, particularly following the acquisition of Akoya Biosciences in 2025. The acquisition has expanded Quanterix’s capabilities, integrating multiplexed tissue imaging with single-cell resolution into its portfolio. Together, these technologies form a uniquely integrated platform that connects biology across blood and tissue, advancing precision medicine from discovery to diagnostics [2].

The conference call will be accessible via phone and webcast, with details provided on the company’s website. Investors are encouraged to review the press release and other relevant documents for a comprehensive understanding of the financial performance and strategic developments [1].

References:
[1] https://www.stocktitan.net/news/QTRX/quanterix-to-report-second-quarter-2025-financial-results-on-august-qmnyqeai4i4l.html
[2] https://www.stocktitan.net/news/QTRX/quanterix-announces-cooperation-agreement-with-kent-lake-iujhye6tm68m.html